The abstract submission system has been closed. Thank you for your great interest in ICAAP12. Below content is for information only. Acceptance or rejection notifications will be sent to submitters on Thursday, September 3, 2015. Only accepted abstracts of presenting authors who have paid their registration fees by Monday, September 14, 2015 will be scheduled for presentation and included for publication.
The 12th ICAAP International Congress on AIDS in Asia and the Pacific welcomes the submission of abstracts in the following scientific tracks:
Sub Track A: The Continuum of Prevention to Treatment and Care: Basic and Clinical Sciences and Epidemiology
Sub Track B: The Continuum of Prevention Treatment and Care: Social Sciences
Sub Track C: Law, Policy and Human Rights and the Unfinished Political and Social Agenda
Sub Track D: Reaching the Unreached Community, Health Systems and Multi-Sectoral Engagement
Sub Track E: Academic Response to HIV (World of learning, teaching and training)
Sub Track F: Faith Based Response and Faith Based Advisory Approach
Sub Track G: Transformational Leadership for an AIDS Free Generation
Sub Track H: Programme for adolescents and youth
Sub Track I: Planning for Post 2015 Development Agenda and Beyond
For detailed descriptions of each scientific track, please visit the track scope and objectives page.
Please click here to view all Track Categories.
TRACK SCOPE AND OBJECTIVES
Download the ICAAP12 Track Scope and Objectives.pdf Here
Track A: The continuum of prevention to treatment and care: basic and clinical sciences and epidemiology
This Track covers basic science, clinical science and epidemiology with an emphasis on their relevance to the Asia Pacific region. All aspects of fundamental HIV biology and the host response to HIV will be considered, including HIV infection and replication, transmission, genetics, pathogenesis, adaptive and innate immune responses to HIV, genetic susceptibility to HIV, interaction of micronutrients and progress in animal models. Pre-clinical vaccines, microbicides, and drug development are themes of this Track. Development of new technologies for HIV diagnosis, issues of drug resistance including drug resistance monitoring and management of treatment failure including salvage therapy are addressed here. Clinical features of opportunistic infections, malignancies, co-morbidities in people living with HIV including TB, STIs and HCV; ART regimens, response to ART, adherence, retention, long term follow-up, management of side effects, ART in specific populations (children, adolescents, elderly, pregnant women) are addressed. Prevention technologies and trials such as of vaccines, microbicides, pre-exposure prophylaxis trials in different population groups, post exposure trials and PMTCT are included. The present state of the epidemic in the region and globally, new methods for surveillance and size estimations of hard to reach populations will be within this Track and tools for monitoring impact and cost effectiveness of different prevention technologies.
HIV biology, Host response, HIV infection, Replication, Transmission, Genetics, Pathogenesis, Immune responses, Genetic susceptibility, Micronutrients, Animal models, Pre-clinical vaccines, Microbicide, Drug development, New technologies, HIV diagnosis, Drug resistance, Monitoring, Management, Treatment failure, Salvage therapy, Opportunistic infections, Malignancies, co-Morbidities, TB, STI, HCV, ART, Adherence, Retention, Long term follow-up, Side effects, Children, Adolescents, Elderly, Pregnant women, Prevention, Technologies, Trials, Vaccines, Pre-exposure, Prophylaxis, Post-exposure, PMTCT, Surveillance, Size estimation , Cost effectiveness, Natural history, Genetics, Mucosal, Mother to child transmission, Synthetic, Injectable , Molecular mechanisms, Diabetes, Cardiovascular, Renal diseases, Bone mineral diseases, Neuro-cognitive disorder, Pharmacology, PMTCT, Key Population, Breastfeeding, First line therapy, Treatment failure, Adverse effect, Immune reconstitution syndrome, Compliance, Palliative care, Micronutrient, Virology, Diagnosis method, Routine testing, Incidence trend, Acquisition of HIV, heterogeneity, Nosocomial infection, Epidemiology, Modeling, effectiveness, CD4 count, Ethical issues, Prevention, Antimicrobial resistance, Blood donation, Pre-natal care, Midwifery, Logistics, Stock out, Sexual Reproductive Health (SRH).
Track B: The continuum of prevention treatment and care: social sciences
This Track explores he social sciences contribute towards an AIDS free generation by focusing on new knowledge and addressing gaps in the translation of behavioural and social science evidence into practice, and to contribute to the building of theory and understanding in HIV-related social science. It includes examination of methodological and programmatic advances in the continuum of prevention research, particularly best practices in HIV prevention for vulnerable populations in resource-limited settings. Strategies to put HIV prevention research into practice, efforts to promote preparedness for bio-medical prevention technologies will be presented. Key populations including sex workers, males who have sex with males (MSM), people who inject drugs, transgender people, migrants, women, children and adolescents will be focused here. The Track promotes understanding of the individual and social determinants of HIV-related risk, vulnerability and impact, to inform development of effective and sustainable HIV responses. This Track features research, analysis and evaluation on psychosocial factors that shape individual attitudes, experiences, and behaviours; social and structural factors that shape vulnerability and risk; social and cultural norms that underlie individual risk and community vulnerability; programmes that promote access to HIV and STI prevention, treatment, care and support.
Behavioural, Social science, Evidence, Theory, Methodological, Programmatic, Continuum of prevention research, Best practices, Vulnerable populations, Resource-limited settings, Preparedness , Bio-medical, Prevention, Technologies, Key populations, Sex workers, Males having sex with males (MSM), People who inject drugs (PWID), Transgender people (TG), Migrants, Women, Children, Adolescents, Determinants, HIV-related risk, Vulnerability ,Impact, Sustainable, analysis, Evaluation, Psychosocial, Attitudes, Experiences, Social, Structural factors , Vulnerability, Risk, Context, Unsafe sex , drug, Alcohol consumption, Violence, Stigma, Discrimination, Policing, Mental health , Discordant, Traditional practices, Poverty, Socio-economic structures, HIV, Family structures, Kinship , Social safety nets, Vulnerable groups, Orphans, Widows, Gender relations, Women, Men, Sexual minorities, Transactional sex, Mobility, Sex work, Migrants, Fertility, Family planning, Reproductive health , HPV, IPV , Novel , Stigmatized , Social network, Hidden individuals, Community , Sexual partners, Community ART delivery models, Adaptation, Teenage sexuality, Community based care, HIV testing , Barriers, Challenges, Digital media, Social networking, Sexual Reproductive Health (SRH), Hijra.
Track C: Law, Policy and Human Rights and the unfinished political and social agenda
This Track addresses the relationship between legal and human rights of key populations and those affected and infected by HIV, and how these laws can affect the epidemic. Examples from countries where changes in laws have enabled access to and provision of better services and countries where punitive laws have hindered such access and provision of services will be presented. Issues around trafficking of drugs and humans, decriminalisation of sex work and drugs, working across borders with law enforcement and governments are included. In addition, local initiatives and partnerships to work on stigma and discrimination are covered under this Track.
Legal, Human rights, Law enforcement, Protection, Empowerment, Stigma, Discrimination, Justice, Policy, Religion, Trafficking, Sexual violence, Drug policy, Harm reduction, Sexual and Reproductive rights, Political economy of HIV, Workplace, Labor rights, Health sector, Sexual Reproductive Health (SRH).
Track D: Reaching the unreached community, Health systems and multi-sectorial engagement
This Track provides new insights into the status of the health systems and its capacity and challenges to expanding treatment and prevention in resource-limited settings. Issues related to health economics, integration of health programmes, country ownership of national health and HIV programmes, and advancement of a comprehensive and integrated approach to health and rights will be discussed.
Resource-limited settings, Health economics, Health programs, Country ownership, Health systems, Human resources, Procurement, Supply management , Laboratory services, Social Protection, Affordable, Quality-assured,TRIPS , Partnerships, Private-public, South-South Partnership, Data Management, Task shifting, Security, Economic determinant, Sexual Reproductive Health (SRH).
Track E: Academic Response to HIV (World of learning, teaching and training)
This Track deals with: medical under-graduate and post graduate clinical courses focusing on HIV/AIDS; courses and curriculum covering public health, population sciences and demography; nursing and midwifery courses; orientation and training of field workers, program leaders/community leaders, supervisors and trainers. This track examines how STI/HIV/AIDS is addressed in pre-service and in-service courses in the Asia Pacific countries and asks how far clinical and social perspectives are built into the courses. Curriculum and courses are examined to identify: where the action oriented emphases are put; how academic courses are evaluated; and how programs are re-designed based on these learnings.
Medical under-graduate, Post graduate, Clinical courses, Courses, Curriculum, Population sciences, Demography, Nursing, Midwifery, Supervisors, ARV, Drug resistance, Curriculum, PEP, Counseling, Palliative care, Public health, PMTCT, Breastfeeding, Sexual Reproductive Health (SRH).
Track F: Faith based response and Faith based advisory approach
This track assesses the faith based response to HIV, examining how a faith based advisory approach can be used for adressing HIV. The scope of this sub-track includes learning about the experiences from different experts in how faith can shape HIV/AIDS prevention advocacy; to explore best practices in inter-faith collaboration for addressing HIV/AIDS issues; to review the relationship between social, cultural and faith in addressing HIV/AIDS.
Faith based, Reproductive Health, HIV/AIDS in Islam, Hinduism, Inter-faith, Sexual Reproductive Health (SRH).
Track G: Transformational Leadership for an AIDS free generation
This Track examines how leadership can shape up development of policies and strategies, and identifies the elements and dynamics of the private sector inter play with public sector. The influence of and the community and civil society influence, evolving formal and informal community leadership, and world experience of community leadership with enabling community engagement is reviewed.
Leadership, Indicators, Benchmarks, Country ownership, Influencing leadership, Successful leadership, functional leadership, Private sector, Developing leaders, Social transformation, Private sector leaders, Corporate Social Responsibility, leadership, Civil society , Community leadership, Financial , Women , Governance, Accountability, Sexual Reproductive Health (SRH).
Track H: Programme for adolescents and youth
This Track explores how to reach the growing number of adolescents and youths in Key Populations and to identify barriers of reaching these people; and identify effective communications messaging channels to reach this group. This track will focus on continuum of prevention, treatment and care that explore how social sciences contribute towards an AIDS free generation, with emphasis on Adolescent (10 – 19 years) and Youth age 20 – 24 years). The session will explore the following key issues: Barriers to HIV testing and counselling, access to condoms, ART and Harm Reduction programme for adolescents (10 – 19 years), HIV disclosure among adolescent (10 – 19 years) and youth(20 – 24 years) living with HIV and implication for sexual health and relationships, Lifelong HIV treatment for adolescent (10 – 19 years) and Youth (20 – 24years), Protection issues for younger adolescents (less than 18 years) in key populations groups, innovative approaches to programming, networking and empowerment with adolescents (10 – 19 years) and young people (20 – 24 years), strategic information gaps and responses needed, role of different media (electronic, print, social) and effective models of service delivery – optimal how-to reach.
Access to information, life skills and health services in relation SRH and HIV for adolescent and youth at large.Lessons on social protection experiences for adolescent and youth.
Adolescents, Youth, Channels of communication, Electronic, print and social media, HIV testing, Developing policies, Religious barriers, Condom, Gatekeeper, social protection, Networking, Sexual Reproductive Health (SRH).
Track I: Planning for post 2015 development agenda
The themes of Track I are, steps of ensuring transparency and accountability regarding activities on information and services on STI/ HIV/AIDS activities in the public and private sectors; mix of clinical and social perspectives for the future plan; role of donors in the future; community involvement in accountability and transparency endeavors; setting up the Monitoring and Evaluation framework for the future; shaping policies and strategies for the future particularly beyond 2015; addressing resource needs for the future; and role of the public – private partnership based activities.
Task shifting, Human resources , Nursing profession in HIV response , Post-2015, SDG, Market economy, Primary health care, Innovation, Best practice, Human Security, Humanitarian disasters, Health diplomacy, Post ICPD/MDG , Disabled, Incarcerated, Elderly, Street Children, Trafficking, Sexual violence, Sexual Reproductive Health (SRH).
The Track category is the general heading under which the abstract will be reviewed and later published in the ICAAP12 materials, if accepted. During the submission process you will be asked to select one track category for your abstract.
Track A: The continuum of prevention to treatment and care: basic and clinical sciences and epidemiology
- New information on virology, immunology, geneticsA1. HIV-1/2: Origins, evolution, regional diversity, G-infection and response to ARV A2. HIV diversity and drug resistanceA3. Immune responses and function in natural history of HIV infectionA4. Immune responses in resistant cohorts: elite controllers and exposed uninfectedA5. Viral determinants of HIV pathogenesisA6. Acute and early HIV infections – are there any variation in Asia Pacific region?A7. Host genetics and HIV infections in Asia PacificA8. Genetics of resistance and susceptibility and restriction factors
A9. Animal models of transmission, disease resistance and progression
A10. Updates on HIV transmission (mucosal and mother to child transmission; other transmission)
- Treatment and biological prevention methodsA11. HIV drug development: synthetic, traditional, injectables and microbicidesA12. Trials of different technologies including vaccines, microbicides, new drugs and approaches for prevention of HIV transmissionA13. Molecular mechanisms of drug action and antiviral drug resistance and drug interactionA14. Updates on vaccine development; Therapeutic Vaccine Vs Preventive VaccineA15. Circumcision
- HIV Co-infections, STIs and other co-morbiditiesA16. HIV co-infections and management of co-infections (TB, HCV, Cryptococcus, bacterial infections, etc.)A17. HIV and non-communicable diseases (diabetes, cardiovascular, renal diseases, bone mineral diseases, HIV and neuro-cognitive disorders)A18. HIV interactions with emerging and other opportunistic pathogensA19. HIV and malignanciesA20. Prevalence of STIs and drug resistance to STIsA21. Improved and rapid testing strategies for STIs, HCV, etc.A22. STI treatment for Key Populations: current approaches, barriers, challenges and alternate optionsA23. HIV Pharmacology
A24. Challenges associated with pre-ART patient care
- Preventing mother to child transmission (PMTCT)A25. Updates on mother to child transmission and other transmissionA26. HIV testing and treatment for HIV positive pregnant women New approaches for HIV preventionA27. PMTCT services for women in Key Populations GroupsA28. Follow-Up care and treatment for HIV-exposed infants (especially those who are HIV negative)A29. Breastfeeding and HIV prevention
- Advances in clinical careA30. First line therapy (when to start, what to start with, durability)A31.Treatment failure: drug resistance, second line therapy and salvage therapyA32. Morbidity and mortality during ARTA33. Antiretroviral therapy in childrenA34. HIV management in adolescentsA35. Antiretroviral therapy in pregnant womenA36. Antiretroviral therapy in the elderlyA37. Adverse effects of antiretroviral therapy including immune reconstitution syndrome
A38.Compliance to ART
A39. Strategies and therapies in palliative care
A40. ART monitoring strategies
A41. Country adaptation of global HIV treatment guidelines
A42. Strategies for ART adherence
A43. Notification and testing of partners by health programs
- Nutrition and HIV
A44. Clinical nutritional care in HIV infection
A45. Effect of micronutrients in HIV and AIDS pathogenesis, transmission and treatment
A46. Mechanisms of micronutrient and HIV interactions
- Rapid diagnostics tools development and use in different settings
A47. Novel assays of immune responses in HIV and AIDS and virological monitoringA48. Rapid and cost-effective HIV screening and diagnostic methodsA49. HIV drug resistance testing (Techniques and Technology)A50. Routine testing in health care settings
- Measuring and monitoring the burden of HIV and its co-morbiditiesA51. Natural history and molecular epidemiology of HIVA52. Monitoring trends in drug resistance among previously untreated patientsA53. HIV prevalence and incidence trends in key populations (sex workers, MSM, prisoners, PWID, migrants) – using different approaches to measure trendsA54. Risk factors for acquisition of HIV, geographic heterogeneity and contextA55. Epidemiology of HIV in general populationA56. Epidemiology of HIV in adolescents and childrenA57. Epidemiology of HIV and other sexually transmitted infections (STI)A58. Epidemiology of HIV and Tuberculosis co-infection
A59. HIV and Malaria co-infection
A60. Epidemiology of HIV and hepatitis Virus
A61. Monitoring ART resistance
A62. Modelling HIV epidemic in the advent of ART
A63. Measuring and modelling the impact of HIV prevention and treatment programs
A64. Measuring cost effectiveness of programs
A65. Methods aimed at measuring recent HIV infections and HIV incidence
A66. Impact and cost effectiveness of starting ART at higher CD4 counts in the Asia Pacific region
A67.Impact evaluation of different models of health service delivery
A68: Sexual behavior, vulnerability and KPs
A69. Ethical issues in epidemiological and prevention research
- Infection control in the HIV era/nosocomial infectionA70. Safety and Antimicrobial resistance transmissionA71. Airborne transmission control (Tuberculosis) in HIV careA72. ART-resistant HIV transmission preventionA73. Tattooing, cosmetics, blood donation and HIV safetyA74. Implementation research for patient safety and HIVA75. HIV and safety in pre-natal care, and midwiferyA76. Patient cantered safe delivery- innovation based systems for HIVA77. HIV Patients for Patient Safety
- Logistics and HIV/AIDS CareA78. Logistics of ARV and Diagnostics tools distributionA79. Lessons from stock out and related issues
Download the ICAAP12 Track A Categories.pdf Here
Track B – The continuum of prevention treatment and care: social sciences
- Determinants of HIV-related behaviours – individual and structuralB1. Context of unsafe sexual practicesB2. Risk taking, drug and alcohol consumptionB3. Violence, stigma and discriminationB4. PolicingB5. Mental health and emotional well beingB6. Discordant couples – managing risk, managing desireB7. Harmful traditional practices and HIVB8. Poverty, social and socio-economic structures and HIV
B9. Family structures, kinship and social safety nets for vulnerable groups (orphans, widows, others)
B10. Gender relations: issues specific to women, men and sexual minorities
- Key populations at riskB11. Drugs and alcohol useB12. Social, behaviour and cultural issues in harm reduction approachesB13. Policing and harm reductionB14. Sex work and other forms of transactional sexB15. Male to male sex, social and psycho-social issuesB16. Transgender, social and psycho-social issuesB17. Mobility, sex work and drug useB18. Migrants
- Women and HIV
B19. Addressing a feminized epidemicB20. Fertility, family planning and reproductive health services and HIVB21. Sexual and reproductive health and HIVB22. HPVB23. Women drugs and HIVB24. IPV
- Methodological Issues in research and programming to reach hidden populationsB25. Novel designs in HIV and AIDS programming and researchB26. Ethical issues in reaching the hard to reach and stigmatised populations including children and migrantsB27. Progress in the use of social networks to reach hidden individualsB28. Community mobilisation for HIV prevention, treatment, care and supportB29. Community involvement in conducting HTCB30. Reaching sexual partners of key populationsB31. Trial of motivational intervention techniques to enhance service uptakeB32. Models of reaching people with POC
B33. Community ART delivery models for high patient’s retention and ensuring good adherence
B34. The role of HTC, and behaviour change counselling, in behaviour change
B35. Sexuality, sexual and reproductive health issues – the broader understanding
- Living with HIV/AIDSB36. Growing up with HIV and adaptation/ teenage sexualityB37. Home and community based care and support including for terminally ill patientsB38. Availability and Access to HIV testing and ART serviceB39. Acceptability and accessibility of services, social/cultural perspectives on understanding medicines and services, i.e. barriers, challenges.B40. Children (0 – 14 years) living with HIV and affected by HIV
- Communication, media and educationB41. HIV and AIDS communication strategiesB42. The media and HIV and AIDSB43. HIV and HIV prevention in the education sectorB44. Digital media, social networking for HIV prevention, treatment, care and supportDownload the ICAAP12 Track B Categories.pdf HereTrack C – Law, Policy and Human Rights and the unfinished political and social agenda
- Law, Policy and Human Rights and the unfinished political and social agenda
C1. Making the law work for the HIV response – Protection, empowerment and involvement of communities
C2. Human rights and HIV services for key populations (prisoners, PWID, sexual minorities and sex workers)
C3. Stigma and discrimination and access to justice
C4. Human rights, ethics and the strategic use of antiretroviral drugs (ARVs) for treatment and prevention
C5. Human rights and HIV testing: bridging the gaps in policy and practice
C6. Human rights, culture, ethnicity and religion in the HIV epidemic
C7. Human trafficking, sexual violence and HIV
C8. Examples of promising case studies addressing legal and human rights challenges
C9. Barriers and challenges to overcome punitive laws and practices
C10. Challenges in addressing cross border movements and access to services
C11. Effective drug policy and harm reduction
C12. Sexual and Reproductive rights, health and HIV
C13. Political economy of HIV
C14. Eliminating discrimination in the workplace: policy enforcement
C15. Sex work and labor rights
C16. Addressing discrimination towards key populations in the workplace
C17. Discrimination in the health sector
Download the ICAAP12 Track C Categories.pdf Here
Track D – Reaching the unreached community, Health systems and multi-sectorial engagement
- HIV and health system strengthening
D1. Leveraging the AIDS response to strengthen health systems and improve other health outcomes
D2. Developing Asia Pacific’s response to the crisis in human resources for health
D3. Procurement and supply management for health care delivery
D4. Health infrastructure and laboratory services
- Shared responsibility and global solidarity towards sustainable AIDS and health agenda
D5. Investing in HIV more strategically – use of applications of investment approach at country level
D6. Social Protection and HIV
D7. Ensuring accelerated access to affordable and quality-assured medicines and health-related commodities
D9. Strategies to integrate HIV interventions with other health and development programs
- Partnerships in HIV
D10. Private-public, and other partnerships for prevention, treatment, care and support (sevice delivery, financing)
D11. Securing resources and capacity for effective partnership
D12. Civil society: A driving force in Getting to Zero – Operationalizing partnership with civil society, people living with HIV and key populations
D13. Exploring South to South Partnership in the HIV response
- Monitoring and evaluation
D14. HIV/AIDS data management information for monitoring and evaluation and evidence-informed decision making
D15. Status and capacity of national health information systems
- Innovation and best practices
D16. Task shifting, sharing and delegation in national programs and responses
D17. Quality and standardisation in the delivery of health service packages
D18. Security, international relations and humanitarian disasters
D19. Socio cultural and economic determinant of HIV
Download the ICAAP12 Track D Categories.pdf Here
Track E – Academic Response to HIV (World of learning, teaching and training)
- Information on under graduate, post graduate clinical course curriculum covering HIV/AIDS:E1. HIV/AIDS taught in different curriculum including ARV, diversity and drug resistance;E2.Topics less covered in the course curriculum in relation to HIV infectionE3. PEP and other infection prevention stepsE4. Counseling before and after HIV testingE5. Acute and early HIV infections – are there any variation in teaching in Asia Pacific region?
- Development, and implementation of nursing and midwifery coursesE6. How elaborate are nursing and midwifery curriculum in developing nurses and midwives for serving persons with HIV infection?E7. Community nursing and midwiferyE8. Palliative care and role of nurses and midwives
- Public Health, demography and allied subjectsE9. Do Public Health and allied subjects cover HIV and management of co-infections (TB, HCV, Cryptococcus, bacterial infections, etc.)?E10. What needs to be undertaken to strengthen Public Health and allied subject courses?E11. How much STI transmission and treatment are covered in the pre-med, nursing and other allied curricula
- Curricula addressing Preventing mother to child transmission (PMTCT) and all associated issuesE12. Courses covering updates on mother to child transmission and all associated issuesE13. Different curricula different aspects of PMTCT including Breastfeeding and HIV prevention
Download the ICAAP12 Track E Categories.pdf Here
Track F – Faith based response and Faith based advisory approach
F1. Responses regarding Reproductive Health and HIV/AIDS in Islam
F2. Christianity values towards HIV/AIDS and sexuality
F3. Hinduism and Buddhism responding to HIV/AIDS and RTI/STI
F4. Inter-faith collaboration in addressing HIV/AIDS within the social and cultural context
Download the ICAAP12 Track F Categories.pdf Here
Track G – Transformational Leadership for an AIDS free generation
- Public sector leadership, policies and politics
G1. Quality of dynamic leadership- indicators and benchmarks to measure the progress to greater country ownership
G2. Policies and politics influencing leadership
G3. Ensuring Governance as a key to a successful leadership
G4. Limitations of functional leadership
- Growing private sector in competition with the public sector
G5. Private sector opportunities in developing leaders
G6. Leaders in the corporate sector influencing social transformation
G7. Complementarity between public and private sector leaders
G8. Corporate Social Responsibility and leadership
- Evolving community leadership
G 9. Civil society and elected community leadership
G10. Societal influence in the norms and practices of community leadership
G11. Financial influences over community leadership
G12. Women and community leadership
G13. Governance and accountability
- Shaping up leadership and capacity building of leaders
G14. Leadership development programs
G15. Do the leaders learn from history?
G16. Factors influencing capacity and skills of leaders
Download the ICAAP12 Track G Categories.pdf Here
Track H – Program for adolescents and youth
- Reaching the adolescents and youth providing information and services on SRH, HIV and AIDS
H1. Barriers for adolescents and youths in reaching HIV prevention, treatment and care services.
H2. Social norms and social perspectives of SRH education and services for adolescent and youth
H3. Channels of communication including electronic, print and social media
H4. Innovations to reach greater number of adolescents
H5. M&E, evaluation and learnings
- Policies and strategies for adolescents and Youth
H6. Policies and strategies implication on adolescent and youth services
H7. Adolescents and youth voices in developing policies
H8. Experience of translating policies and strategies into result based actions
- Social protection services for adolescents and Youth
H9. Social protection services for most at risk adolescents and youths
H10. Social protection for CABA, children of sex workers, street children
H11. HIV/AIDS, SRH education and Life Skill Education on adolescent risk behavior
4. Role of the gatekeepers in reaching the youths and adolescents
H12. Social norms practiced by the gatekeepers
H13. Gatekeeper’s attitude towards the youths and adolescents
H14. Sexual Orientation and Gender Identity (SOGI): implication for adolescent and youths
Download the ICAAP12 Track H Categories.pdf Here
Track I – Planning for post 2015 development agenda
I1. Task shifting to address the crisis of human resources for health
I2. Nursing profession in HIV response
I3. Positioning HIV and Health within the Post-2015 SDG Agenda
I4. Effective national leadership in the evolving market economy
I5. Integrating HIV into primary health care
I6. Impact of HIV response, lessons from the field
I7. Global South to South Partnership in HIV response
I8. Innovation and best practices
I9. Standardisation in the delivery of health service packages
I10. HIV and Human Security,
I11. HIV and humanitarian disasters
I12. HIV and Health diplomacy
I13. HIV response in Post ICPD/MDG
I14. Disabled, Incarcerated, Elderly, Street Children
I15. Human trafficking, sexual violence and HIV
I16: Climate change and HIV
Download the ICAAP12 Track I Categories.pdf Here
Please read the following guidelines carefully before submitting your abstract:
- All abstracts must be written in English.
- Abstracts can only be submitted online via the conference website: http://www.icaap2015.org/; those submitted by fax, post or e-mail will not be considered. All submissions will be acknowledged upon successful submission via the website.
- The abstract text should not exceed 250 words. The number of authors per abstract is unlimited. However, only one author can be listed as the presenting author.
- Use a standard font like Arial when formatting your text. This will help to prevent special characters from getting lost when copying your text to online abstract submission form. Always make sure to check the final abstract with the system’s preview function before submission, and edit or replace as necessary.
- Graphs and images are not allowed.
- It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
- Define all abbreviations and concepts in your abstract at first use.
- For therapeutic agents, only generic names may be used (trade names are not permitted).
- If you have any questions regarding your abstract submission, please contact the abstract support team at email@example.com.
- We support abstract submissions in Bangla. Should you require assistance in translating your abstract from Bangla to English, please contact firstname.lastname@example.org for further information before 20 July. We are happy to provide translation assistance for abstract proposals.
The Conference offers two options for abstract submission: FORMAT A and FORMAT B.
FORMAT A: Classical Scientific Studies
The first option is most suited for scientific research. Abstracts presented under the first option should contain concise statements of:
- Background: indicates the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analyzed or evaluated.
- Methods: describe the setting/location for the study, study design, study population, data collection and methods of analysis used.
- Results: present as clearly as possible the findings/outcome of the study, with specific results in summarized form. Inclusion of gender breakdown of data is strongly encouraged.
- Conclusions: briefly discuss the data and main outcome of the study. Emphasize the significance for HIV prevention, treatment, care and/or support, and future implications of the results.
FORMAT B: Experience-Based Studies
The second option is most suited for presenting new knowledge or analysis that are important for understanding and responding to the HIV epidemic and its future implications. It is suited for information that was gained through systematic forms of knowledge production/ management, by means other than scientific research or evaluation including community level experiences and best practices in response to HIV and AIDS. This process must include some evidence provided through data obtained.
Abstracts presented under the second option should contain concise statements of:
- Issues: a summary of the issue(s) addressed by the abstract.
- Project/activities: a description of the intervention, project, experience, service and/or advocacy.
- Results: a brief description of the results of the project.
- Lessons learned: conclusions and implications of the intervention or project. Data that support the lessons learned and evidence must be included.
We encourage work that introduces new ideas and conceptualizations, research and understandings to the field, as well as analysis of both success and failure.
Your abstract, if accepted, will appear in its full form in the abstract book, and/or on the abstract USB and on the conference and ICAAP website. The USB will be distributed to all registered delegates at the conference.
ICAAP Abstract Transparency Policy
An abstract can be submitted and may be accepted although it has been previously published or presented at a national, regional or international meeting, provided that there are new methods, new findings, updated information or other valid reasons for submitting that can be provided by the author.
If preliminary or partial data has been published or presented, the author is required to indicate the details of that conference, meeting or journal and the reasons for submitting the abstract to this conference. The Scientific Program Committee when making the final decisions will consider this information.
Gender Analysis in Abstracts
Inclusion of gender breakdown of data is strongly encouraged, and should be provided as well as a comprehensive gender analysis in the results section whenever possible. If applicable, your abstract should include the number and percentage of men and women who participated in your research or project, and gender disaggregated data. If your research or project was specific to one gender, please state.
Choosing Abstract Track Categories
The abstract track category is the general heading under which your abstract will be reviewed and later published in the conference printed matters, if accepted. Please choose the category which best describes the subject of your abstract. Abstracts must be allocated to a specific Track, Category and Sub-Category. Refer to the Tracks and Tracks Categories page of the website to get more information.
In addition to the abstract category, please indicate 3-5 keywords (free text, maximum 25 characters per keyword) in bold at the bottom of your abstract. The key words must be representative to the content of the abstract. If relevant, please specify subject/population, setting/location and objective/outcome.
Abstract Blinding and Review
All submitted abstracts will go through a review process carried out by a reviewing committee. Three reviewers will review each abstract.
Notification of Acceptance or Rejection to Corresponding Author
Notification of acceptance or rejection will be sent to the submitting (corresponding) author by Thursday, September 3, 2015. Please note that it is the submitting author’s responsibility to inform all co-authors of the status of the abstract.
Abstract presentation and publication
Only accepted abstracts of presenting authors who have paid their registration fees by Monday, September 14, 2015 will be scheduled for presentation and included for publication.
Download the ICAAP12 Abstract Submission Guidelines.pdf Here